ICU Medical (ICUI) FY2015 results: revenue $342 million, up 10.5% on the year
ICU Medical Inc. (ICUI) reported revenue of $342 million for fiscal 2015, the year ended 31 December 2015, up 10.5% on the year before. Net income was $45 million, up 70.8%, and diluted earnings per share $2.73. The figures are the company's own, from the 10-K it filed with the SEC on 26 February 2016.
Revenue
$342 million
+10.5% on the year
FY2008FY2015
Operating margin
20.1%
12.6% a year earlier
FY2008FY2015
Net income
$45 million
+70.8% on the year
FY2008FY2015
Diluted EPS
$2.73
+62.5% on the year
FY2008FY2015
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Revenue
342
309
314
+10.5%
Cost of revenue
161
158
159
+1.9%
Gross profit
181
151
155
+19.4%
Gross margin
52.9%
49.0%
49.3%
Research and development
15.7
18.3
12.4
-14.3%
Selling, general and administrative
83.2
88.9
89.0
-6.4%
Operating income
68.6
39.0
51.9
+75.6%
Operating margin
20.1%
12.6%
16.6%
Interest expense
0.0
n/a
n/a
Pre-tax income
69.7
39.8
52.7
+75.2%
Income tax
24.7
13.5
12.3
+83.7%
Effective tax rate
35.5%
33.8%
23.3%
Net income
45.0
26.3
40.4
+70.8%
Net margin
13.2%
8.5%
12.9%
Diluted EPS
$2.73
$1.68
$2.65
+62.5%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Operating cash flow
64.2
66.3
65.7
-3.2%
Capital expenditure
13.0
16.6
18.4
-21.8%
Free cash flow
51.2
49.7
47.3
+3.0%
Free cash flow margin
15.0%
16.1%
15.1%
Cash from investing
-11.2
-21.8
-13.1
Cash from financing
15.7
13.6
24.4
+14.9%
Depreciation and amortisation
18.1
19.4
19.5
-7.1%
Share-based compensation
12.8
9.6
5.4
+33.7%
Buybacks
1.5
5.8
3.0
-73.9%
Diluted shares, weighted
16m
16m
15m
+5.4%
Shares outstanding at period end
16m
16m
15m
+3.1%
Balance sheet
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Shareholders' equity
580
508
465
+14.1%
Debt
0.0
0.0
0.0
Other liabilities
47.0
32.9
34.9
+42.9%
Total liabilities and equity
627
541
500
+15.8%
Fixed assets
74.3
86.1
87.9
-13.7%
Goodwill
6.5
1.5
1.5
+337.3%
Intangible assets
23.9
7.1
8.5
+238.9%
Investments
41.2
71.0
70.9
-41.9%
Cash and equivalents
336
276
226
+21.9%
Receivables
57.8
39.1
45.3
+48.1%
Inventory
43.6
36.9
34.5
+18.1%
Other assets
43.2
23.7
25.2
+82.2%
Total assets
627
541
500
+15.8%
10-K for the year ended 31 December 2015, filed 26 February 2016: the filing.